0000912282-16-000570.txt : 20160216 0000912282-16-000570.hdr.sgml : 20160215 20160216145755 ACCESSION NUMBER: 0000912282-16-000570 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160216 DATE AS OF CHANGE: 20160216 GROUP MEMBERS: MM ASSET MANAGEMENT INC. GROUP MEMBERS: MMCAP INTERNATIONAL INC. SPC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001208261 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-82315 FILM NUMBER: 161426943 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 940 CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 646-440-9310 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 940 CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: EPICEPT CORP DATE OF NAME CHANGE: 20021129 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MMCAP International Inc. SPC CENTRAL INDEX KEY: 0001304857 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: P.O. BOX 32021, SMB STREET 2: ADMIRAL FINANCIAL CENTRE, 90 FORT STREET CITY: GRAND CAYMAN STATE: E9 ZIP: BWI BUSINESS PHONE: 416-408-0997 MAIL ADDRESS: STREET 1: P.O. BOX 32021, SMB STREET 2: ADMIRAL FINANCIAL CENTRE, 90 FORT STREET CITY: GRAND CAYMAN STATE: E9 ZIP: BWI SC 13G/A 1 mmcap_sc13ga-immune.htm mmcap_sc13ga-immune.htm
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 

SCHEDULE 13G

Amendment No. 1

INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934

IMMUNE PHARMACEUTICALS INC.
(Name of Issuer)



COMMON STOCK
(Title of Class of Securities)



45254C101
(CUSIP Number)


December 31, 2015
(Date of Event Which Requires Filing of This Statement)


Check the Appropriate box to designate the rule pursuant to which this schedule is filed:

o Rule 13d-1(b)
x Rule 13d-1(c)
o Rule 13d-1(d)
 


 
 
 
 
CUSIP No. 45254C101
13G
Page 2 of 6 Pages



1
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
 
 
MMCAP International Inc. SPC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 
(a) þ
(b) o
 
     
3
SEC USE ONLY
 
     
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Cayman Islands
 
5
SOLE VOTING POWER
NUMBER OF
  
0
SHARES
6
SHARED VOTING POWER
BENEFICIALLY
  
2,697,949*
OWNED BY
7
SOLE DISPOSITIVE POWER
EACH
  
0
REPORTING
8
SHARED DISPOSITIVE POWER
PERSON WITH
  
2,697,949*
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,697,949*
*The reporting persons own 1,291,402 common shares, Series A warrants convertible into 520,833 common shares, Series B warrants convertible into 535,714 common shares, Series C warrants convertible into 100,000 common shares and Series D warrants convertible into 250,000 common shares.
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*         o
 
     
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
8.51%
12
TYPE OF REPORTING PERSON*
 
CO
*SEE INSTRUCTIONS BEFORE FILLING OUT!


 
 
 
 
CUSIP No. 45254C101
13G
Page 3 of 6 Pages



1
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
 
 
MM Asset Management Inc.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 
(a) þ
(b) o
 
     
3
SEC USE ONLY
 
     
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Ontario, Canada
 
5
SOLE VOTING POWER
NUMBER OF
  
0
SHARES
6
SHARED VOTING POWER
BENEFICIALLY
  
2,697,949*
OWNED BY
7
SOLE DISPOSITIVE POWER
EACH
  
0
REPORTING
8
SHARED DISPOSITIVE POWER
PERSON WITH
  
2,697,949*
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,697,949*
*The reporting persons own 1,291,402 common shares, Series A warrants convertible into 520,833 common shares, Series B warrants convertible into 535,714 common shares, Series C warrants convertible into 100,000 common shares and Series D warrants convertible into 250,000 common shares.
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*         o
 
     
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
8.51%**
**The percentages used herein are calculated based upon 30,280,739 outstanding shares as of November 11, 2015, plus 1,406,547 common shares in aggregate underlying warrants which are beneficially owned by the reporting persons and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended.
12
TYPE OF REPORTING PERSON*
 
CO
*SEE INSTRUCTIONS BEFORE FILLING OUT!

 
 
 
CUSIP No. 45254C101
13G
Page 4 of 6 Pages


Item 1                 (a).           Name of Issuer:

Immune Pharmaceuticals Inc.

Item 1                 (b).           Address of Issuer’s Principal Executive Offices:

430 East 29th Street, Suite 940
New York, NY 10016

Item 2                 (a).           Name of Person Filing:

i) MMCAP International Inc. SPC

ii) MM Asset Management Inc.

Item 2                 (b).           Address of Principal Business Office or, if None, Residence:

i)  P. O. Box 32021 SMB, Admiral Financial Centre
     90 Fort Street
     Grand Cayman, Cayman Islands KY1-1208

ii)  66 Wellington Street West, Suite 2707
       Toronto, Ontario M5K 1H6 Canada

Item 2                 (c).           Citizenship:

i) Cayman Islands
ii) Ontario, Canada

Item 2                 (d).           Title of Class of Securities:

Common Stock

Item 2                 (e).           CUSIP Number:

45254C101

Item 3.
If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 
(a)
  
Broker or dealer registered under Section 15 of the Act;
 
 
(b)
  
Bank as defined in Section 3(a)(6) of the Act;
 
 
(c)
  
Insurance Company as defined in Section 3(a)(19) of the Act;
 
 
(d)
  
Investment Company registered under Section 8 of the Investment Company Act;
 
 
(e)
  
Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
 
 
(f)
  
Employee benefit plan or endowment plan in accordance with Rule 13d-1(b)(1)(ii)(F);
 
 
(g)
  
Parent holding company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G);
 
 
(h)
  
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
 
 
(i)
  
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940:
 
 
(j)
  
Group, in accordance with Rule 13d-1(b)(1)(ii)(j).
 
 
 
  þ
If this statement is filed pursuant to Rule 13d-1(c), check this box.
 
 
 
 
CUSIP No. 45254C101
13G
Page 5 of 6 Pages

 
Item 4.
Ownership.
   
 
Provide the following information regarding the aggregate number and percentage of the class of securities identified in Item 1.
   
  (a)
Amount beneficially owned:   2,697,949*
     
  (b)
Percent of class:   8.51%
     
  (c)
Number of shares as to which such person has:
     
    (i) Sole power to vote or to direct the vote:  0
       
    (ii) Shared power to vote or to direct the vote:  2,697,949*
       
    (iii) Sole power to dispose or to direct the disposition of:  0
       
    (iv)
Shared power to dispose or to direct the disposition of:  2,697,949*
 
*The reporting persons own 1,291,402 common shares, Series A warrants convertible into 520,833 common shares, Series B warrants convertible into 535,714 common shares, Series C warrants convertible into 100,000 common shares and Series D warrants convertible into 250,000 common shares.

**The percentages used herein are calculated based upon 30,280,739 outstanding shares as of November 11, 2015, plus 1,406,547 common shares in aggregate underlying warrants which are beneficially owned by the reporting persons and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended.
 

Instruction.  For computations regarding securities which represent a right to acquire an underlying security, see Rule 13d-3(d)(1).

Item 5.
Ownership of Five Percent or Less of a Class.
 
 
If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
 
 
N/A
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
 
 
N/A
 
Item 8.
Identification and Classification of Members of the Group.
 
 
N/A
 
Item 9.
Notice of Dissolution of Group.
 
 
N/A
 

 
 
 
CUSIP No. 45254C101
13G
Page 6 of 6 Pages


Item 10.                      Certification.  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
February 16, 2016
 
(Date)
   
 
MMCAP International Inc. SPC
 
 
By:  /s/ Matthew MacIsaac      
Matthew MacIsaac, Director
   
   
 
February 16, 2016
 
(Date)
   
 
MM Asset Management Inc.
 
 
By:  /s/ Hillel Meltz      
Hillel Meltz, President